The market capacity is growing.
China's urbanization level is expected to reach 58.5% by 2020, according to a study by the national development and reform commission. Urbanization will drive consumption growth, the citizens of new consumption concept and consumption demand qualitative change will happen, and therefore safer, more reliable and use more comfortable disposable sterile medical polymer products consumption space is huge. With the continuous improvement of people's living standard, the continuous enhancement of health consciousness, the deepening of urbanization and the increase of the proportion of aging, the market size of disposable medical polymer products will continue to grow.
In recent years, the continuous deepening of the reform of China's medical and health system and the deepening of the reform of the medical system have laid a solid foundation for the realization of the universal health care system in the year. The consummation of the medical system drives the market demand for the disposable medical macromolecule products.
In addition, with the development of the state of epidemic and infectious diseases prevention and control measures, and with the economic and social development, as a result of living environment and people's living habits change, some noncommunicable diseases incidence began to rise sharply, is expected to drive the rapid growth of the disposable medical polymer products market demand, for disposable medical products manufacturers to provide a broad space for growth.
The integration and upgrading of domestic industry is an inevitable trend.
Although the total market of disposable polymer medical products in China continues to grow, the products are mainly concentrated in low-end products, and the benefits are not obvious. Domestic disposable sterile medical polymer products production enterprise product homogeneity, low in severe cases, easy to form a price war between enterprises as the leading factor of vicious competition situation, some companies even at less than or close to the cost price to occupy the market, the short-term behavior not conducive to the long-term development of the industry. The disposable medical polymer products industry of our country exist a large number of domestic, mill type production enterprise, the enterprise scale and the low level of technology, production quality is uneven, the production environment is poor and can't guarantee product quality and after-sales service, etc. As the Labour cost and raw material prices continue to rise, the deepening of industrial structure upgrade, some can't form scale effect and low production qualification, technical level of manufacturing enterprises will lose the competitive advantage in the market. In addition, the external pressures and challenges brought by other emerging market countries such as Brazil and India cannot be ignored.
In disposable medical polymer products, therefore, the future of the industry competition, on the one hand, requires enterprises to improve product competitive advantage, through the application of new materials and new technology, the improvement of product quality standards, improving the processing technology and so on ways to improve the grade of the product, jump out at the lower level product level in the face of the homogeneous competition situation. , on the other hand, the domestic production enterprises, small scale, but according to the overall layout, the region is relatively concentrated, it is such as to establish an orderly competition between the enterprises and reasonable division of labor cooperation, forming a single variety scale development put forward higher requirements. Future disposable medical polymer products manufacturing enterprises both need to take advantage of economies of scale to reduce the production cost, also need to establish the form of medical consumables industry base, to strengthen the leading products, improve product's reliability, security and strengthening the service for the future development direction, differentiation to improve enterprise competition ability, and bargaining power in the market.
It is the trend of the industry to increase the added value of products.
The traditional disposable sterile medical polymer products are usually use their physical properties in the course of treatment, surgery, or nursing has the bacterial resistance, prevent infection and relieve patients' pain, and so on, these features rely mainly on the physical properties of material used and production process control to achieve. With the development of clinical medicine, combining drugs with traditional medical polymer products is an important trend in the development of disposable sterile medical polymer products. For example, in the wound and wound care, just attached to enter into the field of clinical application of targeted to repair damaged cells for dressing of trace elements and promote cell regeneration, such as alginate biological dressings and other dressings with pharmaceutical ingredients. Such dressing compared to traditional dressings in addition to traditional for the wound to create a sterile environment and prevent wound infection, also can promote epithelial cell regeneration, inhibit the growth of granulation tissue excessive, eventually the wound site to lessen the effect of scar, promote the healing of the wound. With the constant improvement of the people on treatment and nursing, rising industry competition and enterprise of competitive differentiation and break low-quality, the homogeneity competition on the market at present situation of the strong desire, the combined treatment with medical products in order to enhance product added value of disposable sterile medical products will be the industry an important development trend in the future.
To integrate the circulation and reduce the circulation cost.
The price of medical equipment is inflated, the problem is mainly not in the production process, the virtual high part is mainly produced in the circulation link. In general, medical consumables from the manufacturer to the hospital, usually through the first level agency, regional agents, provincial agents and other levels, each turnover at least 30 percent of the profit bonus.
According to the price bureau of guangdong province survey report, in all hospitals surveyed, 89% of the hospitals buy medical consumables, mainly from the wholesale enterprises 11% of the hospitals were purchased from wholesale and production enterprises at the same time, namely the majority of medical consumables, it takes the wholesaler of the intermediate links, and circulation markup percentage and mark-up are lack of effective supervision. At the same time, according to the report, in the middle of circulation, the guangdong province high value medical consumables in general from the factory (or import) to sell to patients, medical institutions is 2-3 times the average price, individual products and even up to ten times. These medical consumables of resupply, layer upon layer markups, hence the inflated prices seriously harm the interests of patients (source: bureau of guangdong province the medical consumable price research report (2011)).
From the beginning of entering the disposable medical products industry, the publisher started to build a nationwide sales platform and medical logistics network, and directly established a supply relationship with major hospitals. By covering a wide range of sales network, we avoid the high price problem caused by the circulation channel, and establish the brand image of low quality and low price in hospitals and patients.
It reduces the risk of infection and improves the quality and safety of medical service.
At present, hospital infection control rate has become an important index in hospital evaluation system. In the early days, mainly some foreign disposable medical products enterprise product with its worldwide in close cooperation with medical staff and fully grasp of diagnosis and treatment, operation process, through its covering the diagnosis and treatment, operation process each link of the disposable hygiene, protection product to reduce the medical staff and patients' risk of infection. However, due to the higher prices of foreign products, the medical costs are increased. And in our country, the cost control is the need to consider one of the important factors in the patients and hospital management, especially in most of the relatively less developed areas in our country, through large-scale application of disposable medical products and popularized in clinical application of comprehensive medical infection prevention measures.
After the establishment of the issuer and the subsequent quite a long period of time, our country is the main domestic, mill type production on medical consumables industry, its characteristic is the size of the manufacturer and the low level of technology, production quality is uneven, the production environment is poor and can't guarantee product quality and after-sales service, etc., and the resulting of the national hospital infections and medical accident has been at a higher level. Hospital infection and complications not only affects the patient's postoperative rehabilitation and life safety will cause additional medical expenses, patients and hospitals and social bring huge economic burden to patients and medical resources waste, of hospital infection and even affect social stability. The control of hospital infection rate by hospitals and medical institutions at all levels provided the impetus for the market growth of disposable medical polymer products.